Subtype
Infratentorial Neoplasm
CI-CAN-00005577Explore in graph →
Non-malignant110 active trials7 evidence items
Loading cancer entity…
Subtype
CI-CAN-00005577Explore in graph →
Clinical trials
372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06396481 | Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma(CSAγδTBMG) | not yet recruiting | Early Phase 1 | 25 | Beijing Tiantan HospitalOTHER | 1 | May 2, 2024 | clinicaltrials |
Data updated 22 days agoSource updated May 2, 2024source: clinicaltrials